Effect of nettle extract and exercise in type 2 diabetic patients

Phase 2

• Conditions: Diabetes mellitus type 2.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT2015031021412N1
• Lead Sponsor: Shahroud University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

female gender over the age of 50 years old; HbA1c levels equal or less than 10%; common diabetes drugs usage (Metformin and Glibenclamide); patients with triglyceride levels less than 400 mg dL-1.

Exclusion criteria: patients with cardiovascular; renal; liver; thyroid diseases; infections; allergies; angina; the regular use of NSAIDs (Non-Steroid Anti Inflammatory Drugs); warfarin; alcohol; herbal tea; dietary supplements; insulin injection.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FPG. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;TG. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;SOD. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;NO. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;SGPT. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;SGOT. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;HDL. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.;LDL. Timepoint: After and before 8 weeks of continuous treatment. Method of measurement: Blood test.